02.04.2019 13:05:00

Merck Reports Successful Completion Of Cash Tender Offer For Immune Design

(RTTNews) - Merck (MRK) announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of Immune Design (IMDZ) at a purchase price of $5.85 per share. The company reported that, as of the tender offer expiration, 41,970,607 shares of common stock of Immune Design were validly tendered and not withdrawn from the tender offer, representing approximately 86.75 percent of the outstanding common stock of Immune Design on a fully diluted basis.

Merck expects to complete the acquisition of Immune Design on April 2 through a merger of Merck's subsidiary with and into Immune Design in which all shares not tendered into the offer will be canceled and converted into the right to receive cash equal to the $5.85 offer price per share without interest, less any applicable withholding taxes.

Nachrichten zu Immune Design Corpmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Immune Design Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Merck Co. 97,20 0,41% Merck Co.